Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03032913 | Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC(PANC-CTC) | completed | — | 52 | University Hospital, BordeauxOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT00789958 | S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct | completed | Phase 2 | 105 | SWOG Cancer Research NetworkNETWORK | 1 |
| Apr 9, 2018 |
| clinicaltrials |
| NCT01888978 | Molecularly Tailored Therapy for Pancreas Cancer | completed | Phase 2 | 19 | Georgetown UniversityOTHER | 1 | Apr 9, 2018 | clinicaltrials |
| NCT03469375 | Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer | completed | — | 41 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 27, 2018 | clinicaltrials |
| NCT02132325 | Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer | completed | N/A | 19 | Mayo ClinicOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT01280058 | Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer | completed | Phase 2 | 73 | National Cancer Institute (NCI)NIH | 1 | Mar 9, 2018 | clinicaltrials |
| NCT01394159 | 22G FNA Needle vs. 22G ProCore Needle | completed | N/A | 56 | AdventHealthOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT01024387 | AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors | completed | Phase 2 | 60 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 8, 2018 | clinicaltrials |
| NCT00805688 | Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer | completed | — | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 6, 2018 | clinicaltrials |
| NCT02680990 | Resilience and Exercise in Advanced Cancer Treatment(REACT) | completed | N/A | 14 | Milton S. Hershey Medical CenterOTHER | 1 | Feb 28, 2018 | clinicaltrials |
| NCT01734967 | Needle-based Confocal Endomicroscopy Examination of Pancreatic Masse | completed | N/A | 28 | Herlev HospitalOTHER | 2 | Feb 23, 2018 | clinicaltrials |
| NCT03444051 | Comparison of Two Endoscopic Biopsic Needles for Pancreatic Tumors(Mousquetaires) | completed | — | 68 | Société Française d'Endoscopie DigestiveOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT01423604 | Study of Ruxolitinib in Pancreatic Cancer Patients(RECAP) | completed | Phase 2 | 136 | Incyte CorporationINDUSTRY | 1 | Feb 12, 2018 | clinicaltrials |
| NCT01963325 | S-1 in Combination With Abraxane in Treating Cholangiocarcinoma | completed | Phase 2 | 50 | Yuhong LiOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT01843725 | Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers(MOMENTUM1) | completed | Phase 1 | 37 | Jules Bordet InstituteOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT02806648 | A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)(PALBONET) | completed | Phase 2 | 21 | Grupo Espanol de Tumores NeuroendocrinosOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT00365144 | Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine | completed | Phase 2 | 36 | University of California, San FranciscoOTHER | 1 | Jan 19, 2018 | clinicaltrials |
| NCT01769248 | Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle(MUCIN) | completed | N/A | 140 | Northwestern UniversityOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01781520 | Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 47 | Capital Medical UniversityOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02459041 | Clinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph Nodes(ADVEUS) | completed | — | 100 | University of Medicine and Pharmacy CraiovaOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT01677559 | Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies | completed | Phase 1 | 34 | Washington University School of MedicineOTHER | 1 | Jan 11, 2018 | clinicaltrials |
| NCT00033241 | Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors | completed | Phase 1 | — | OSI PharmaceuticalsINDUSTRY | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00040183 | OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. | completed | Phase 3 | 569 | OSI PharmaceuticalsINDUSTRY | 17 | Jan 10, 2018 | clinicaltrials |
| NCT00810719 | Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | completed | Phase 2 | 30 | University of California, DavisOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT01234935 | Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery | completed | Phase 2 | 8 | Translational Oncology Research InternationalOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT01043172 | A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection | completed | Phase 2 | 72 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 3, 2018 | clinicaltrials |
| NCT01589328 | Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB(EPADE-PB) | completed | N/A | 288 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 3, 2018 | clinicaltrials |
| NCT01146054 | Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma | completed | Phase 2 | 59 | Stanford UniversityOTHER | 1 | Dec 19, 2017 | clinicaltrials |
| NCT00290693 | Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer | completed | Phase 2 | 45 | University of MiamiOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 37 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00201838 | Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma | completed | Phase 1 / Phase 2 | 38 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Nov 30, 2017 | clinicaltrials |
| NCT00620295 | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00703638 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 16 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00667082 | NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma | completed | Phase 1 | 22 | CelgeneINDUSTRY | 1 | Nov 22, 2017 | clinicaltrials |
| NCT01430052 | Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer | completed | Phase 2 | 110 | Osaka Medical Center for Cancer and Cardiovascular DiseasesOTHER | 1 | Nov 21, 2017 | clinicaltrials |
| NCT02272738 | A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer | completed | Phase 1 | 54 | Osaka Medical Center for Cancer and Cardiovascular DiseasesOTHER | 1 | Nov 21, 2017 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01392027 | Biospecimens for Identification of Diseases of the Pancreas.(SPORE-PANC) | completed | N/A | 712 | University of MichiganOTHER | 1 | Nov 8, 2017 | clinicaltrials |
| NCT01213758 | Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT | completed | — | 14 | University of AarhusOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT01836237 | The Use of Wound Protector in Whipple's Procedure With Intrabiliary Stent | completed | N/A | 107 | University of CalgaryOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT03320980 | RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma | completed | — | 30 | Moscow Clinical Scientific CenterOTHER | 0 | Oct 25, 2017 | clinicaltrials |
| NCT00383760 | Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2017 | clinicaltrials |
| NCT01320254 | PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)(PiCCA) | completed | Phase 2 | 93 | Hannover Medical SchoolOTHER | 1 | Oct 12, 2017 | clinicaltrials |
| NCT03302637 | Oral Microbiome and Pancreatic Cancer | completed | — | 732 | NYU Langone HealthOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00584363 | Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection(SPORE) | completed | — | 731 | University of Alabama at BirminghamOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT02920944 | Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions | completed | N/A | 35 | Seung Bae YoonOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT02241187 | Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection | completed | N/A | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 27, 2017 | clinicaltrials |
| NCT02017015 | Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer(PANC-001) | completed | Phase 2 | 83 | CelgeneINDUSTRY | 1 | Sep 26, 2017 | clinicaltrials |
| NCT02486497 | Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining | completed | N/A | 40 | Seoul National University HospitalOTHER | 1 | Sep 25, 2017 | clinicaltrials |
| NCT01897415 | Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer | completed | Phase 1 | 16 | University of PennsylvaniaOTHER | 1 | Sep 19, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Apr 10, 2018source: clinicaltrials